Cargando…

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies

The dismal prognosis of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) prompted recent advances in the field of therapeutic approaches beyond cytotoxic cancer therapy. In recent years, the deeper and increasing knowledge on the genomic landscape and the upcoming new data on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavalieri, Stefano, Filippini, Daria Maria, Ottini, Arianna, Bergamini, Cristiana, Resteghini, Carlo, Colombo, Elena, Lombardo, Roberta, Nuzzolese, Imperia, Alfieri, Salvatore, Licitra, Lisa, Locati, Laura D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Open Exploration 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400733/ https://www.ncbi.nlm.nih.gov/pubmed/36046116 http://dx.doi.org/10.37349/etat.2021.00062

Ejemplares similares

The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports
por: Colombo, Elena, et al.
Publicado: (2023)

HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients
por: Cavalieri, Stefano, et al.
Publicado: (2023)

Bleeding complications in patients with squamous cell carcinoma of the head and neck
por: Bergamini, Cristiana, et al.
Publicado: (2021)

Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment
por: Galbiati, Donata, et al.
Publicado: (2019)

The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients
por: Cavalieri, Stefano, et al.
Publicado: (2022)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

Mining of Self-Organizing Map Gene-Expression Portraits Reveals Prognostic Stratification of HPV-Positive Head and Neck Squamous Cell Carcinoma
por: Locati, Laura D., et al.
Publicado: (2019)

Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma
por: Alfieri, Salvatore, et al.
Publicado: (2020)

Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events
por: Grisanti, Salvatore, et al.
Publicado: (2019)

Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor–Expressing Salivary Gland Cancer: A Phase II Trial
por: Locati, Laura D., et al.
Publicado: (2021)

Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak
por: Resteghini, Carlo, et al.
Publicado: (2020)

Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures
por: Serafini, Mara S., et al.
Publicado: (2020)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of Aqualief(TM) Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia
por: Iacovelli, Nicola Alessandro, et al.
Publicado: (2021)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?
por: Bossi, Paolo, et al.
Publicado: (2017)

Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature
por: Giannini, Lorenzo, et al.
Publicado: (2023)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019)

Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
por: Pisani, Silvia, et al.
Publicado: (2022)

The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
por: Economopoulou, Panagiota, et al.
Publicado: (2017)

Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report
por: Locati, Laura Deborah, et al.
Publicado: (2022)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma
por: Cristina, Valerie, et al.
Publicado: (2019)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma: a narrative review
por: Sharon, Shay, et al.
Publicado: (2022)

Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023)

929TiP HERODOTUS: Head and neck cancers international COVID-19 collaboration: An international registry on head and neck cancer with COVID-19
por: Psyrri, A., et al.
Publicado: (2021)

Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data
por: De Cecco, Loris, et al.
Publicado: (2015)

Integrative miRNA-Gene Expression Analysis Enables Refinement of Associated Biology and Prediction of Response to Cetuximab in Head and Neck Squamous Cell Cancer
por: De Cecco, Loris, et al.
Publicado: (2017)

RANK expression in EBV positive nasopharyngeal carcinoma metastasis: a ready-to-treat target?
por: Resteghini, Carlo, et al.
Publicado: (2017)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

Targeting Angiogenesis in Squamous Cell Carcinoma of the Head and Neck: Opportunities in the Immunotherapy Era
por: Saba, Nabil F., et al.
Publicado: (2022)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy
por: Damasio, Marcos Paulo S., et al.
Publicado: (2022)

Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Argiris, Athanassios, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jliuiqbqmhb5jl7od8rnqrm22